Regulatory Blog

Clinical trials play a critical role in evaluating the safety and effectiveness of medicines before they are made available to patients. In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA)  provides guidance to help sponsors and researchers comply with regulatory requirements for clinical trials involving medicinal products. This article provides a consolidated overview of MHRA guidance covering several key areas of clinical trial regulation,

I still remember sitting in the back of my chemistry class, flipping through massive textbooks just to compare atomic weights or understand a single element. A single question often meant turning dozens of pages. It was slow, and honestly, it sometimes took the excitement out of learning. Fast forward to today, and learning science has completely transformed. Instead of digging through hundreds of pages, we can now explore information instantly with interactive tools. That’s

The U.S. Food and Drug Administration (FDA) has issued guidance documents to help pharmaceutical manufacturers understand regulatory expectations related to market exclusivity for drug products  and responses to inspection findings following CGMP inspections . These guidances support transparency in regulatory processes and help industry ensure compliance with quality and development requirements. Guidance: New Clinical Investigation Exclusivity (3-Year Exclusivity) for Drug